WallStreetZenWallStreetZen

NASDAQ: RCEL
Avita Medical Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RCEL past revenue growth

How has RCEL's revenue growth performed historically?
Company
37.03%
Industry
9.34%
Market
17.33%
RCEL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RCEL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RCEL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RCEL earnings and revenue history

Current Revenue
$51.6M
Current Earnings
-$35.4M
Current Profit Margin
-68.6%

RCEL Return on Equity

Current Company
-54.8%
Current Industry
10.5%
Current Market
188%
RCEL's Return on Equity (-54.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RCEL announces earnings.

RCEL Return on Assets

Current Company
-38.1%
Current Industry
5.3%
RCEL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RCEL Return on Capital Employed

Current Company
-34.71%
Current Industry
8.3%
RCEL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RCEL vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RCEL$51.57M-$32.79M-$35.38M+32.54%N/A
SENS$22.39M-$48.01M-$60.39M+3.43%N/A
ARAY$447.48M-$5.64M-$14.55M+1.68%N/A
SMLR$68.18M$24.70M$20.58M+25.98%+30.13%
TLSI$18.51M-$58.31M-$59.04M+48.44%N/A
View Top Medical Device Stocks

RCEL earnings dates

Next earnings date
May 13, 2024

Avita Medical Earnings & Revenue FAQ

What were RCEL's earnings last quarter?

On Invalid Date, Avita Medical (NASDAQ: RCEL) reported Q4 2023 earnings per share (EPS) of -$0.28, up 27.27% year over year. Total Avita Medical earnings for the quarter were -$7.07 million. In the same quarter last year, Avita Medical's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Avita Medical stock.

What was RCEL's earnings growth in the past year?

As of Q2 2024, Avita Medical's earnings has grown year over year. Avita Medical's earnings in the past year totalled -$35.38 million.

What is RCEL's earnings date?

Avita Medical's earnings date is Invalid Date. Add RCEL to your watchlist to be reminded of RCEL's next earnings announcement.

What was RCEL's revenue last quarter?

On Invalid Date, Avita Medical (NASDAQ: RCEL) reported Q4 2023 revenue of $14.25 million up 36% year over year. In the same quarter last year, Avita Medical's revenue was $10.48 million.

What was RCEL's revenue growth in the past year?

As of Q2 2024, Avita Medical's revenue has grown 37.03% year over year. This is 27.69 percentage points higher than the US Medical Devices industry revenue growth rate of 9.34%. Avita Medical's revenue in the past year totalled $51.57 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.